tweetindex
TR

Dana-Farber ✓

@DanaFarber · Boston, Massachusetts · joined 30 Jun 2008

Dana-Farber Cancer Institute - a leading center for expert, compassionate cancer care and advanced research. Appts: 877-442-3324 | https://t.co/HvCwkLltic

112 364Followers
8 916Following
34 967Posts total
87.2KViews on collected posts

Son gönderiler

Please join us in congratulating Benjamin L. Ebert, MD, PhD, on being named to @BosBizJournal's Power 50-Movement Makers list. We’re proud to celebrate Ebert’s leadership and the impact he continues to make as we advance the future of care through the Lavine Bekenstein Cancer 1.2K views · 9 likes · 5 reposts · 0 replies Open on X →
We are proud to announce that @usnews has recognized Dana-Farber/Boston Children's Cancer and Blood Disorders Center as the #1 pediatric cancer program in the nation in its 2026-27 Best Children's Hospitals report. Dana-Farber/Boston Children’s has been recognized as one of ht
5.4K views · 45 likes · 10 reposts · 1 replies Open on X →
What can the microbes found in tumors tell us about cancer? Researchers analyzed more than 16,000 tumor genomes, creating a map that could help scientists investigate how microorganisms interact with cancer and potentially inform future care. 🔗⬇️ https://t.co/C7Mk2MBq2v 2.1K views · 8 likes · 1 reposts · 0 replies Open on X →
In 2020, @CKadoch of @kadochlab received an email from a gynecologic oncologist with a research idea. That idea, proposed by @Jstlaurent_MD of @stlaurentlab, has led to findings that support clinical testing of a completely new way to treat endometrial cancer, the fourth most htt
0:55
4.2K views · 39 likes · 9 reposts · 2 replies Open on X →
Join Ursula A. Matulonis, MD, of @DFCIGynOnc and other expert guests in exploring recent breakthroughs, evolving standards, and emerging therapies across gynecologic cancers. Watch the @OncLive series here: https://t.co/W6PqmqWJFP 2.4K views · 7 likes · 1 reposts · 0 replies Open on X →
Join experts in radiation oncology, medical physics, healthcare operations, and cancer center leadership for a multidisciplinary symposium on the emerging role of upright proton therapy. Register before September 4 for early bird pricing: https://t.co/YLBBQpMZaK https://t.co/vWEy 1.8K views · 6 likes · 2 reposts · 0 replies Open on X →
@DanaFarber @TheJimmyFund @FDA Thank you DFCI! You are the best! 💗🙏🏻 63 views · 0 likes · 0 reposts · 0 replies Open on X →
@DanaFarber @FDA Too bad Kras colon cancer patients can't get it yet. ☹️ 26 views · 0 likes · 0 reposts · 0 replies Open on X →
@DanaFarber @FDA Florida is doing trials on untraditional treatments like vitamin c infusion, ivermectin…etc why not the 3rd best hospital? 36 views · 1 likes · 0 reposts · 1 replies Open on X →
The @FDA has approved daraxonrasib for adult patients with previously treated metastatic pancreatic cancer. The approval is based primarily on results from the Dana-Farber-led RASolute 302 trial showing daraxonrasib nearly doubled median overall survival versus chemotherapy. ht 3.7K views · 61 likes · 16 reposts · 5 replies Open on X →
We’re pleased to share that Sonal Gandhi has been hired as Senior Vice President (SVP) of Campus Operations and Infrastructure, responsible for a broad portfolio which includes strategic oversight and excellence of facilities operations, capital construction, real estate, public 3.3K views · 15 likes · 0 reposts · 0 replies Open on X →
@DanaFarber Thank you @ASCO for sharing that historic moment, heartfelt reaction & sense of community. And keeping the wry joke at the end! The full human condition ... compassion, excitement, optimism & not being willing to wait for the speaker to finish his statement! #TheR 514 views · 6 likes · 0 reposts · 1 replies Open on X →
@DanaFarber Anktiva performed better than Revolution's drug in pancreatic cancer trials. Revolution's trial included second-line patients only who failed one prior therapy. Ibrx's pancreatic cancer trial patients were 3rd through 6th line who failed multiple prior therapies and h 357 views · 5 likes · 0 reposts · 0 replies Open on X →
@DanaFarber The standing ovation wasn’t really for daraxonrasib. It was for 40 years of frustration finally beginning to crack. To understand why thousands of oncologists stood up, you have to understand what pancreatic cancer has been. Pancreatic cancer is not just another ca 505 views · 17 likes · 2 reposts · 1 replies Open on X →
A historic moment at #ASCO26: more than 9,000 oncologists rose for three standing ovations as Brian Wolpin, MD, MPH, Director of the Hale Family Center for Pancreatic Cancer Research, presented promising new Phase 3 results for an investigational treatment for metastatic https://
1:00
61.7K views · 816 likes · 188 reposts · 11 replies Open on X →

Aynı büyüklükteki hesaplara karşı

Son 90 güne ait 11 gönderi, 100K–1M takipçi aralığıyla yan yana. boyutuna göre olağan erişim, çoğundan daha zayıf tepki.

Medyan görüntülenme2 059bu hesap5 983100K–1M için medyan
Erişim, %1.83%bu hesap1.49%100K–1M için medyan
Etkileşim, %0.46%bu hesap0.93%100K–1M için medyan
ÖlçütBu hesap100K–1M için medyanOran
Gönderi başına medyan görüntülenme2 0595 9830.34×
Erişim (görüntülenme ÷ takipçi)1.83%1.49%1.23×
Etkileşim oranı0.46%0.93%0.49×

Bu aralıktaki diğer hesaplar →   Başka bir hesapla karşılaştır →   Bu kıyas değerleri nasıl kuruluyor →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

5052 Jun
3573 Jun
514
3.3K24 Aug
3.7K26 Aug
36
2627 Aug
63
1.8K
2.4K1 Sep
4.2K8 Sep
2.1K11 Sep
5.4K15 Sep
1.2K16 Sep

Last 14 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

3.96%2 Jun
1.40%3 Jun
1.36%
0.46%24 Aug
2.23%26 Aug
5.56%
0.00%27 Aug
0.00%
0.44%
0.34%1 Sep
1.20%8 Sep
0.44%11 Sep
1.10%15 Sep
1.18%16 Sep

Reactions — likes, reposts, replies and quotes — divided by views. Median for 100K–1M accounts is 0.93%.

What the audience does

Likes71.9%1 035 in total
Reposts16.2%234 in total
Replies1.5%22 in total
Quotes2.2%31 in total
Bookmarks8.2%118 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Benzer hesaplar